Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low Placental Growth Factor Across Pregnancy Identifies a Subset of Women With Preterm Preeclampsia

30 May 2012

Abstract excerpt

Preeclampsia is a heterogeneous syndrome affecting 3% to 5% of all pregnancies. An imbalance of the antiangiogenic and proangiogenic factors, soluble receptor fms-like tyrosine kinase 1 and placental growth factor (PGF), is thought to contribute to the pathophysiology of preeclampsia. Maternal plasma PGF and soluble receptor fms-like tyrosine kinase 1 were quantified by specific immunoassays in cross-sectional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Birth, Development, and Health
Share to Pregnancy and preeclampsia studies
Share to Reproductive System and Pregnancy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22647886
DOI: 10.1161/hypertensionaha.112.191213

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low Placental Growth Factor Across Pregnancy Identifies a Subset of Women With Preterm PreeclampsiaPMID 22647886Read ↗

Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disordersSemantic proximity Read ↗

Preeclampsia: The Role of Angiogenic Factors in Its PathogenesisSemantic proximity Read ↗

A Review of the Diagnosis, Risk Factors, and Role of Angiogenetic Factors in Hypertensive Disorders of PregnancySemantic proximity Read ↗

Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsiaSemantic proximity Read ↗

The vascular endothelial growth factor family in adverse pregnancy outcomesSemantic proximity Read ↗

Preeclampsia and Angiogenic ImbalanceSemantic proximity Read ↗

Change in Amniotic Fluid Levels of Multiple Anti-Angiogenic Proteins before Development of Preeclampsia and Intrauterine Growth RestrictionSemantic proximity Read ↗

Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis.Semantic proximity Read ↗

An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsiaSemantic proximity Read ↗

A Common Profile of Disordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth RestrictionSemantic proximity Read ↗

The Promise of Angiogenic Markers for the Early Diagnosis and Prediction of PreeclampsiaSemantic proximity Read ↗

The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia: a secondary analysis of the INSPIRE trialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.